Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (5,539,903)	$ (1,707,496)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation expense	27,947	17,380
Amortization of patents	69,428	78,458
Common stock and options for compensation, consulting and vendor services	1,128,274	1,031,623
Equity loss on joint venture	2,445,489	910,200
Changes in operating assets and liabilities:
Increase in accounts receivable	(207,248)	(8,623)
Increase in other receivable	(58,140)
Increase in inventories	(875,034)	(1,175,447)
(Increase) decrease to advances on contracts	(450,407)	1,587,155
(Increase) decrease to prepaid expenses and other current assets	192,601	(304,114)
Increase in other assets	(2,670)	(1,768)
Increase (decrease) in accounts payable	173,068	(516,460)
Increase in accrued expenses and other payables	220,038	466,035
Net cash (used in) provided by operating activities	(2,946,338)	376,943
Cash flows from investing activities:
Purchases of intangible assets	(9,939)	(16,752)
Purchases of property and equipment	(67,581)	(82,210)
Net cash used in investing activities	(3,727,271)	(1,304,528)
Cash flows from financing activities:
Proceeds from exercise of stock options		348,697
Net proceeds on Private Placement Offering		9,449,683
Repayment of related party loan		(50,000)
Capital contribution from noncontrolling interest	500,000	400,000
Net cash provided by financing activities	500,000	10,148,380
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(6,173,609)	9,220,795
Cash and cash equivalents at beginning of year	10,367,993	1,147,198
Cash and cash equivalents at end of year	4,194,384	10,367,993
Supplemental disclosure of cash flow information:
Net Assets Acquired from Variable Interest Entity	566,775
Milestone Medical Inc. [Member]
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Equity loss on joint venture	2,019,211	891,500
Cash flows from investing activities:
Investment in Joint Venture		(856,105)
Investment in Milestone Medical prior to consolidation (Note F)	(3,649,751)
Milestone Education LLC [Member]
Cash flows from operating activities:
Net loss	(7,846)	(17,889)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Equity loss on joint venture	7,846	17,890
Milestone China [Member]
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Equity loss on joint venture	$ 348,651	810
Cash flows from investing activities:
Investment in Joint Venture		$ (349,461)